Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 8/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24532390 | 0.93 | CA2 (0.33) | ALDH1A1TDP1CA2DNM1TSHR | |
| SCHEMBL7104457 | 0.92 | OPRM1 (0.39) | CA2DNM1TSHRCA1FDPS | |
| SCHEMBL6662072 | 0.90 | LMNA (0.39) | ALDH1A1CA2DNM1TSHRFDPS | |
| SCHEMBL779887 | 0.83 | CYP3A4 (0.31) | TSHRCYP3A4 | |
| SCHEMBL4362883 | 0.82 | DNM1 (0.46) | ALDH1A1CA2DNM1TSHRFDPS | |
| SCHEMBL11449395 | 0.81 | LMNA (0.47) | ALDH1A1CA2TSHRCYP3A4FDPS | |
| SCHEMBL779882 | 0.76 | — | — | |
| SCHEMBL18716706 | 0.75 | DNM1 (0.33) | ALDH1A1TDP1CA2DNM1CA1 | |
| SCHEMBL28226870 | 0.74 | DNM1 (0.36) | ALDH1A1TDP1CA2DNM1TSHR | |
| SCHEMBL11385298 | 0.73 | LMNA (0.38) | ALDH1A1CA2DNM1TSHRCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215888-A1 | TOPICAL NAIL FORMULATION | NUVO RESEARCH INC. (CA) | 2009-08-27 | — | — | US | claimed |
| EP-1909772-A1 | TRANSDERMAL DRUG DELIVERY FORMULATION | Nuvo Research Inc. (CA) | 2008-04-16 | — | — | EP | claimed |
| WO-2007098591-A2 | TOPICAL NAIL FORMULATION | NUVO RESEARCH INC. (CA) | 2007-09-07 | — | — | WO | claimed |
| WO-2007016766-A1 | TRANSDERMAL DRUG DELIVERY FORMULATION | NUVO RESEARCH INC. (CA) | 2007-02-15 | — | — | WO | claimed |
| EP-3357908-B1 | METHOD FOR PRODUCING ALDEHYDE COMPOUND OR KETONE COMPOUND | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2020-12-09 | — | — | EP | disclosed |
| EP-3357898-B1 | METHOD FOR PRODUCING ORGANIC COMPOUND | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2020-11-25 | — | — | EP | disclosed |
| US-10351512-B2 | Method of producing organic compound | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-07-16 | — | — | US | disclosed |
| US-20180244604-A1 | METHOD OF PRODUCING ORGANIC COMPOUND | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2018-08-30 | — | — | US | disclosed |
| EP-3357898-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | Fujifilm Finechemicals Co., Ltd. (JP) | 2018-08-08 | — | — | EP | disclosed |
| EP-3357908-A1 | METHOD FOR PRODUCING ALDEHYDE COMPOUND OR KETONE COMPOUND | Fujifilm Finechemicals Co., Ltd. (JP) | 2018-08-08 | — | — | EP | disclosed |
| US-20090215888-A1 | TOPICAL NAIL FORMULATION | NUVO RESEARCH INC. (CA) | 2009-08-27 | — | — | US | disclosed |
| US-20080319092-A1 | Transdermal Drug Delivery Formulation | NUVO RESEARCH INC. (CA) | 2008-12-25 | — | — | US | disclosed |
| WO-2007098591-A2 | TOPICAL NAIL FORMULATION | NUVO RESEARCH INC. (CA) | 2007-09-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180244604-A1 | METHOD OF PRODUCING ORGANIC COMPOUND | LPO, OR10J3, AOX1 | ALDH1A1 790/4885TDP1 4578/4885CA2 1957/4885 |
| US-10351512-B2 | Method of producing organic compound | LPO, OR10J3, AOX1 | ALDH1A1 790/4885TDP1 4578/4885CA2 1957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.